by TractManager | Mar 31, 2023 | Emerging Technology Report
Lenire is a bimodal neuromodulation device combining sound and transmucosal electrical tongue stimulation to temporarily relieve the symptoms of tinnitus in patients ≥ 18 years of age with at least moderate tinnitus. Lenire therapy is intended to be self-administered...
by TractManager | Mar 27, 2023 | Emerging Technology Report
Etranacogene dezaparvovec (Hemgenix; formerly AMT-061) is an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with hemophilia B (congenital factor IX deficiency) who currently use factor IX prophylaxis therapy, have current or...
by TractManager | Mar 24, 2023 | Molecular Test Assessment
This report evaluates the clinical validity and clinical utility of the Cologuard test (Exact Sciences Corp.).If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Mar 23, 2023 | Emerging Technology Report
Aortix is a percutaneous mechanical circulatory support device for the treatment of chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure with worsening renal function.If you have a Hayes login, click...
by TractManager | Mar 17, 2023 | Emerging Technology Report
Zavegepant is an intranasal novel small-molecule, calcitonin gene-related peptide (CGRP) receptor antagonist indicated for the acute treatment of migraine with or without aura in adults.If you have a Hayes login, click here to view the full report on the Knowledge...
Recent Comments